Cargando…
Evaluation of a Triage Checklist for Mild COVID-19 Outpatients in Predicting Subsequent Emergency Department Visits and Hospitalization during the Isolation Period: A Single-Center Retrospective Study
Managing mild illness in COVID-19 and predicting progression to severe disease are concerning issues. Here, we investigated the outcomes of Japanese patients with mild COVID-19, and identified triage risk factors for further hospitalization and emergency department (ED) visits at a single tertiary h...
Autores principales: | Tanaka, Yasuhiro, Yamamoto, Kazuko, Morimoto, Shimpei, Nabeshima, Takeshi, Matsushima, Kayoko, Ishimoto, Hiroshi, Ashizawa, Nobuyuki, Hirayama, Tatsuro, Takeda, Kazuaki, Gyotoku, Hiroshi, Iwanaga, Naoki, Takemoto, Shinnosuke, Fukahori, Susumu, Takazono, Takahiro, Yamaguchi, Hiroyuki, Kido, Takashi, Sakamoto, Noriho, Hosogaya, Naoki, Akabame, Shogo, Sugimoto, Takashi, Yamanashi, Hirotomo, Matsui, Kosuke, Izumida, Mai, Fujita, Ayumi, Tashiro, Masato, Tanaka, Takeshi, Ariyoshi, Koya, Furumoto, Akitsugu, Morita, Kouichi, Izumikawa, Koichi, Yanagihara, Katsunori, Mukae, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506197/ https://www.ncbi.nlm.nih.gov/pubmed/36143099 http://dx.doi.org/10.3390/jcm11185444 |
Ejemplares similares
-
A case of Strongyloides hyperinfection syndrome with elevated IgG4
por: Takao, Ryota, et al.
Publicado: (2023) -
Safety and efficacy of 5-aminolevulinic acid phosphate/iron in mild-to-moderate coronavirus disease 2019: A randomized exploratory phase II trial
por: Tanaka, Takeshi, et al.
Publicado: (2023) -
Decreased community-acquired pneumonia coincided with rising awareness of precautions before governmental containment policy in Japan
por: Tashiro, Masato, et al.
Publicado: (2023) -
Efficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study)
por: Yamamoto, Kazuko, et al.
Publicado: (2021) -
Serum Cytokines Usefulness for Understanding the Pathology in Allergic Bronchopulmonary Aspergillosis and Chronic Pulmonary Aspergillosis
por: Ito, Yuya, et al.
Publicado: (2022)